81 related articles for article (PubMed ID: 10406817)
1. Glucagon receptor gene mutation (Gly40Ser) in human essential hypertension: the PEGASE study.
Brand E; Bankir L; Plouin PF; Soubrier F
Hypertension; 1999 Jul; 34(1):15-7. PubMed ID: 10406817
[TBL] [Abstract][Full Text] [Related]
2. Glucagon receptor Gly40Ser amino acid variant in Sardinian hypertensive non-insulin-dependent diabetic patients. Sardinian Diabetic Genetic Study Group (SDGSG).
Tonolo G; Melis MG; Ciccarese M; Secchi G; Atzeni MM; Li LS; Luthman H; Maioli M
Acta Diabetol; 1997 Aug; 34(2):75-6. PubMed ID: 9325468
[TBL] [Abstract][Full Text] [Related]
3. Physiological and genetic characterization of the Gly40Ser mutation in the glucagon receptor gene in the Sardinian population. The Sardinian Diabetes Genetic Study Group.
Tonolo G; Melis MG; Ciccarese M; Secchi G; Atzeni MM; Maioli M; Pala G; Massidda A; Manai M; Pilosu RM; Li LS; Luthman H; Maioli M
Diabetologia; 1997 Jan; 40(1):89-94. PubMed ID: 9028723
[TBL] [Abstract][Full Text] [Related]
4. Association of Trp64Arg beta 3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population.
Tonolo G; Melis MG; Secchi G; Atzeni MM; Angius MF; Carboni A; Ciccarese M; Malavasi A; Maioli M
J Hypertens; 1999 Jan; 17(1):33-8. PubMed ID: 10100091
[TBL] [Abstract][Full Text] [Related]
5. Role of the Gly40Ser mutation in the glucagon receptor gene in Brazilian patients with type 2 diabetes mellitus.
Shiota D; Kasamatsu T; Dib SA; Chacra AR; Moisés RS
Pancreas; 2002 May; 24(4):386-90. PubMed ID: 11961492
[TBL] [Abstract][Full Text] [Related]
6. Screening for the Gly40Ser mutation in the glucagon receptor gene among patients with type 2 diabetes or essential hypertension in Taiwan.
Huang CN; Lee KC; Wu HP; Tai TY; Lin BJ; Chuang LM
Pancreas; 1999 Mar; 18(2):151-5. PubMed ID: 10090412
[TBL] [Abstract][Full Text] [Related]
7. Altered renal sodium handling and hypertension in men carrying the glucagon receptor gene (Gly40Ser) variant.
Strazzullo P; Iacone R; Siani A; Barba G; Russo O; Russo P; Barbato A; D'Elia L; Farinaro E; Cappuccio FP
J Mol Med (Berl); 2001 Oct; 79(10):574-80. PubMed ID: 11692154
[TBL] [Abstract][Full Text] [Related]
8. A linkage and cross-sectional study of hypertension and obesity using a poly (A) Alu-repeat polymorphism at the glucagon receptor gene locus (17q25).
Rutherford S; Boatwright SD; Samwell GA; Morris BJ; Griffiths LR
Clin Exp Pharmacol Physiol; 1998; 25(7-8):627-9. PubMed ID: 9673441
[TBL] [Abstract][Full Text] [Related]
9. Hypothesis: glucagon receptor glycine to serine missense mutation contributes to one in 20 cases of essential hypertension.
Morris BJ; Chambers SM
Clin Exp Pharmacol Physiol; 1996 Dec; 23(12):1035-7. PubMed ID: 8977155
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the Gly40Ser polymorphism in the glucagon receptor gene in a German non-insulin-dependent diabetes mellitus population.
Ambrosch A; Lobmann R; Dierkes J; König W; Luley C; Lehnert H
Clin Chem Lab Med; 1999 Jul; 37(7):719-21. PubMed ID: 10510728
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland.
Huang X; Orho M; Lehto M; Groop L
Diabetologia; 1995 Oct; 38(10):1246-8. PubMed ID: 8690179
[TBL] [Abstract][Full Text] [Related]
12. Gly40Ser polymorphism of the glucagon receptor gene is associated with central adiposity in men.
Siani A; Iacone R; Russo O; Barba G; Russo P; Cappuccio FP; Galletti F; Strazzullo P
Obes Res; 2001 Nov; 9(11):722-6. PubMed ID: 11707539
[TBL] [Abstract][Full Text] [Related]
13. [Gly40Ser mutation of glucagon receptor gene and NIDDM in Han nationality].
Deng H; Tang WL; Pan Q
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):291-3. PubMed ID: 12536714
[TBL] [Abstract][Full Text] [Related]
14. Influence of family history on frequency of glucagon receptor Gly40Ser mutation in hypertensive subjects.
Morris BJ; Jeyasingam CL; Zhang W; Curtain RP; Griffiths LR
Hypertension; 1997 Dec; 30(6):1640-1. PubMed ID: 9403595
[No Abstract] [Full Text] [Related]
15. The 825C/T polymorphism of the G-protein subunit beta3 is not related to hypertension.
Brand E; Herrmann SM; Nicaud V; Ruidavets JB; Evans A; Arveiler D; Luc G; Plouin PF; Tiret L; Cambien F
Hypertension; 1999 May; 33(5):1175-8. PubMed ID: 10334807
[TBL] [Abstract][Full Text] [Related]
16. Different frequencies of inducible nitric oxide synthase genotypes in older hypertensives.
Glenn CL; Wang WY; Morris BJ
Hypertension; 1999 Apr; 33(4):927-32. PubMed ID: 10205225
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of the glucagon receptor gene and non-insulin-dependent diabetes mellitus in the Russian population.
Babadjanova G; Reincke M; Mora P; Chuchalin A; Allolio B
Exp Clin Endocrinol Diabetes; 1997; 105(4):225-6. PubMed ID: 9285210
[TBL] [Abstract][Full Text] [Related]
18. Gly40Ser mutation of glucagon receptor gene and essential hypertension in Japanese.
Fujisawa T; Ikegami H; Babaya N; Ogihara T
Hypertension; 1996 Dec; 28(6):1100. PubMed ID: 8952603
[No Abstract] [Full Text] [Related]
19. The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon.
Hansen LH; Abrahamsen N; Hager J; Jelinek L; Kindsvogel W; Froguel P; Nishimura E
Diabetes; 1996 Jun; 45(6):725-30. PubMed ID: 8635644
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension.
Bengtsson K; Melander O; Orho-Melander M; Lindblad U; Ranstam J; Råstam L; Groop L
Circulation; 2001 Jul; 104(2):187-90. PubMed ID: 11447084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
